Rolf Terlinden

1.5k total citations
32 papers, 1.2k citations indexed

About

Rolf Terlinden is a scholar working on Small Animals, Pharmacology and Physiology. According to data from OpenAlex, Rolf Terlinden has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Small Animals, 10 papers in Pharmacology and 8 papers in Physiology. Recurrent topics in Rolf Terlinden's work include Veterinary Pharmacology and Anesthesia (11 papers), Pain Mechanisms and Treatments (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Rolf Terlinden is often cited by papers focused on Veterinary Pharmacology and Anesthesia (11 papers), Pain Mechanisms and Treatments (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Rolf Terlinden collaborates with scholars based in Germany, United States and Belgium. Rolf Terlinden's co-authors include Thomas Tzschentke, Claudia Lange, Ulrich Jahnel, Helmut Buschmann, W. Straßburger, A. Römer, Babette Kögel, Thomas Christoph, Werner Englberger and Johannes Schneider and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Biochemistry and Biochemical Pharmacology.

In The Last Decade

Rolf Terlinden

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf Terlinden Germany 17 459 380 348 286 216 32 1.2k
H.‐H. Hennies Germany 9 484 1.1× 308 0.8× 277 0.8× 216 0.8× 190 0.9× 12 895
Michael Cwik United States 16 103 0.2× 162 0.4× 74 0.2× 383 1.3× 107 0.5× 30 947
Richard B.R. Muijsers Netherlands 12 297 0.6× 119 0.3× 27 0.1× 88 0.3× 81 0.4× 15 712
F. O. Holley United States 10 87 0.2× 304 0.8× 49 0.1× 189 0.7× 115 0.5× 16 903
Fumio Moriya Japan 20 64 0.1× 62 0.2× 66 0.2× 107 0.4× 147 0.7× 79 1.2k
Randall L. Tackett United States 16 256 0.6× 15 0.0× 175 0.5× 174 0.6× 88 0.4× 73 1.1k
Karl Verebely United States 14 140 0.3× 182 0.5× 27 0.1× 44 0.2× 95 0.4× 19 889
William A. Olson United States 16 79 0.2× 235 0.6× 394 1.1× 234 0.8× 109 0.5× 35 796
Gerardo Reyes-Garcı́a Mexico 20 432 0.9× 43 0.1× 30 0.1× 105 0.4× 196 0.9× 77 984
James C. Kraner United States 18 93 0.2× 60 0.2× 49 0.1× 29 0.1× 108 0.5× 51 1.2k

Countries citing papers authored by Rolf Terlinden

Since Specialization
Citations

This map shows the geographic impact of Rolf Terlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Terlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Terlinden more than expected).

Fields of papers citing papers by Rolf Terlinden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Terlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Terlinden. The network helps show where Rolf Terlinden may publish in the future.

Co-authorship network of co-authors of Rolf Terlinden

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Terlinden. A scholar is included among the top collaborators of Rolf Terlinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Terlinden. Rolf Terlinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pusecker, Klaus, et al.. (2015). Determination of tapentadol and tapentadol-O-glucuronide in human serum samples by UPLC–MS/MS. Journal of Chromatography B. 981-982. 40–47. 15 indexed citations
2.
Kögel, Babette, Rolf Terlinden, & Johannes Schneider. (2014). Characterisation of tramadol, morphine and tapentadol in an acute pain model in Beagle dogs. Veterinary Anaesthesia and Analgesia. 41(3). 297–304. 44 indexed citations
3.
Smit, Johan W., et al.. (2013). Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations. International Journal of Clinical Pharmacology and Therapeutics. 51(4). 338–348. 28 indexed citations
4.
Raffa, Robert B., Helmut Buschmann, Thomas Christoph, et al.. (2012). Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opinion on Pharmacotherapy. 13(10). 1437–1449. 113 indexed citations
5.
Schröder, Wolfgang, Thomas Tzschentke, Rolf Terlinden, et al.. (2011). Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia. Journal of Pharmacology and Experimental Therapeutics. 337(1). 312–320. 100 indexed citations
6.
Terlinden, Rolf, et al.. (2010). In vitro and in vivo characterization of tapentadol metabolites. Methods and Findings in Experimental and Clinical Pharmacology. 32(1). 31–31. 58 indexed citations
7.
Xu, Xu Steven, et al.. (2010). Population Pharmacokinetics of Tapentadol Immediate Release (IR) in Healthy Subjects and Patients with Moderate or Severe Pain. Clinical Pharmacokinetics. 49(10). 671–682. 25 indexed citations
8.
Smit, Johan W., Charles Oh, Jens Rengelshausen, et al.. (2009). Effects of Acetaminophen, Naproxen, and Acetylsalicylic Acid on Tapentadol Pharmacokinetics: Results of Two Randomized, Open‐Label, Crossover, Drug‐Drug Interaction Studies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(1). 25–34. 36 indexed citations
9.
Kneip, Christa, Rolf Terlinden, Horst Beier, & Genfu Chen. (2008). Investigations Into the Drug-Drug Interaction Potential of Tapentadol in Human Liver Microsomes and Fresh Human Hepatocytes. Drug Metabolism Letters. 2(1). 67–75. 61 indexed citations
10.
Terlinden, Rolf, et al.. (2007). Absorption, metabolism, and excretion of14C-labeled Tapentadol HCl in healthy male subjects. European Journal of Drug Metabolism and Pharmacokinetics. 32(3). 163–169. 85 indexed citations
11.
Tzschentke, Thomas, Rolf Terlinden, H.‐H. Hennies, et al.. (2006). Tapentadol hydrochloride. Analgesic, Mu-opioid receptor agonist, noradrenaline reuptake inhibitor. Drugs of the Future. 31(12). 1053–1061. 99 indexed citations
12.
13.
Terlinden, Rolf, et al.. (2006). (689). Journal of Pain. 7(4). S26–S26. 8 indexed citations
14.
Murthy, B. V. R., et al.. (2000). Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration. British Journal of Anaesthesia. 84(3). 346–349. 87 indexed citations
15.
Schneider, Johannes, Elmar Friderichs, Babette Kögel, et al.. (1993). Taprostene Sodium. Cardiovascular Drug Reviews. 11(4). 479–500. 9 indexed citations
16.
Clement, Bernd, et al.. (1992). Reduction of Amidoxime Derivatives to Pentamidine in vivo.. Archiv der Pharmazie. 325(1). 61–62. 33 indexed citations
17.
Terlinden, Rolf, et al.. (1990). Pharmacokinetics and toxicokinetics of pentamidine in rats after intravenous and aerosol application.. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 85. 245–247. 2 indexed citations
18.
Müller, A., Holger Gabriel, Helmut Sies, et al.. (1988). A novel biologically active selenooorganic compound—VII. Biochemical Pharmacology. 37(6). 1103–1109. 57 indexed citations
19.
Terlinden, Rolf, et al.. (1988). Determination of the two major metabolites of ebselen in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 430(2). 438–442. 16 indexed citations
20.
Fischer, Hartmut, et al.. (1988). A Novel Biologically Active Selenoorganic Compound. VIII. Biotransformation of Ebselen. Xenobiotica. 18(12). 1347–1359. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.‐H. Hennies Breakdown of academic impact, for papers by Michael Cwik Breakdown of academic impact, for papers by Richard B.R. Muijsers Breakdown of academic impact, for papers by F. O. Holley Breakdown of academic impact, for papers by Fumio Moriya Breakdown of academic impact, for papers by Randall L. Tackett Breakdown of academic impact, for papers by Karl Verebely Breakdown of academic impact, for papers by William A. Olson Breakdown of academic impact, for papers by Gerardo Reyes-Garcı́a Breakdown of academic impact, for papers by James C. Kraner
Rankless by CCL
2026